Related Experiment Video
Updated: Jun 16, 2026

Genetic Incorporation of Biosynthesized L-dihydroxyphenylalanine (DOPA) and Its Application to Protein Conjugation
Published on: August 24, 2018
Outcomes beyond phenylalanine: an international perspective.
Francois Feillet1, Anita MacDonald, Danielle Hartung Perron
1Reference Centre for Inborn Errors of Metabolism, INSERM U954, Department of Pediatrics, Children's Hospital of Nancy, Allée du Morvan, Vandoeuvre les Nancy 54500, France. f.feillet@chu-nancy.fr
Comprehensive phenylketonuria (PKU) management requires more than just controlling blood phenylalanine (Phe) levels. Integrating psychosocial support and addressing lifelong needs is crucial for optimal outcomes and empowering individuals with PKU.
Area of Science:
- Biochemistry
- Psychology
- Genetics
Background:
- Phenylketonuria (PKU) requires lifelong management of blood phenylalanine (Phe) levels for optimal outcomes.
- Despite biochemical control, subtle cognitive deficits and psychiatric issues can still arise in individuals with PKU.
- Current management often overlooks crucial psychosocial aspects and long-term needs.
Purpose of the Study:
- To review PKU management strategies extending beyond biochemical control.
- To highlight the role of psychologists in PKU care across the lifespan.
- To address challenges in transitioning to adulthood and explore non-traditional PKU management practices.
Main Methods:
- Literature review focusing on comprehensive PKU management.
- Analysis of the role of psychological support in PKU.
- Exploration of challenges faced by individuals with PKU during life transitions.
- Investigation of non-traditional therapeutic approaches for PKU.
Main Results:
- Psychosocial support is integral to managing PKU and its associated burdens.
- Transitioning to adulthood presents unique challenges for individuals with PKU.
- Non-traditional practices may offer supplementary benefits to standard PKU care.
- A holistic approach is essential for empowering individuals with PKU.
Conclusions:
- Effective PKU management necessitates a comprehensive strategy beyond Phe level control.
- Psychological and social support are critical for improving quality of life in PKU.
- Addressing lifelong needs and transition challenges enhances patient outcomes.
- Integrating diverse support systems optimizes the potential for individuals with PKU to achieve life goals.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Inborn Errors of Metabolism
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
